Anixa Biosciences Inc (13)

Browse by Contract Category

Contracts

Amendment 2 to the Collaboration Agreement between the Company and MolGenie GmbH. (Certain information has been redacted in the marked portions of the exhibit.) (Filed With SEC on June 10, 2021)
Assignment Agreement dated May 1, 2021, between the Company, OntoChem GmbH and MolGenie GmbH (Filed With SEC on June 10, 2021)
Form of Underwriter Warrants (Filed With SEC on March 24, 2021)
Amendment to License Agreement between Certainty Therapeutics, Inc. and The Wistar Institute of Anatomy and Biology. (Certain information has been redacted in the marked portions... (Filed With SEC on March 11, 2021)
Amended and Restated Underwriting Agreement, dated March 22, 2021, between Anixa Biosciences, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 24, 2021)
Joint Development and Option Agreement, dated January 26, 2021, between the Company and The Cleveland Clinic Foundation. (Certain information has been redacted in the marked... (Filed With SEC on March 11, 2021)
Form of Warrant issued to Acorn Management Partners LLC (Filed With SEC on January 7, 2021)
Amendment 2 to the Collaboration Agreement between Certainty Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc. (.) (Certain information has been... (Filed With SEC on January 7, 2021)
Amendement to Collaboration Agreement between the Company and OntoChem GmbH (Filed With SEC on January 7, 2021)
Exclusive License Agreement, dated October 20, 2020, between the Company and The Cleveland Clinic Foundation. (.) (Certain information has been redacted in the marked portions of... (Filed With SEC on January 7, 2021)
Redactions with respect to certain portions hereof denoted with *** COLLABORATION AGREEMENT (Filed With SEC on June 9, 2020)
Redactions with respect to certain portions hereof denoted with “***” EXCLUSIVE LICENSE AGREEMENT between THE CLEVELAND CLINIC FOUNDATION and ANIXA BIOSCIENCES, INC. dated as... (Filed With SEC on September 6, 2019)
AMENDMENT 1 TO THE COLLABORATION AGREEMENT BETWEEN CERTAINTY THERAPEUTICS, INC. AND H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Filed With SEC on September 6, 2019)